{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:10:15Z","timestamp":1767651015794},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ejphar.2010.09.067","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T09:34:46Z","timestamp":1287048886000},"page":"472-478","source":"Crossref","is-referenced-by-count":5,"title":["Effect of a novel biphenyl compound, VMNS2e on ob\/ob mice"],"prefix":"10.1016","volume":"650","author":[{"given":"Sucheta B.","family":"Kurundkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narsingh","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisan M.","family":"Kodam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vithal M.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash L.","family":"Bodhankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram S.","family":"Ghole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.09.067_bb0005","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/clinchem\/33.12.2153","article-title":"Fructosamine: structure, analysis, and clinical usefulness","volume":"33","author":"Armbruster","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0010","unstructured":"Bailey, C.J., Flatt, P.R., 1997. Animal syndromes of non-insulin dependent diabetes mellitus, In: Pickup, J.C., Williams, G. (Eds.), Textbook of Diabetes, second ed. Blackwell, Oxford, pp. 23.1\u201323.25."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1152\/ajpendo.1999.276.3.E443","article-title":"Effect of leptin deficiency on metabolic rate in ob\/ob mice","volume":"276","author":"Breslow","year":"1999","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0020","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/clinchem\/37.7.1252","article-title":"Clinical validation of a second-generation fructosamine assay","volume":"37","author":"Cefalu","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0025","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1152\/ajpendo.00141.2004","article-title":"Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR\u03b3 agonists","volume":"289","author":"Cha","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0030","first-page":"380","article-title":"Management of obesity in NIDDM (non-insulin dependent diabetes mellitus)","volume":"39","author":"Cheah","year":"1998","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/187221407779814570","article-title":"Dipeptidyl peptidase-IV inhibitors: an evolving treatment for type 2 diabetes from the incretin concept","volume":"1","author":"Chyan","year":"2007","journal-title":"Recent Patents on Endocrine, Metabolic & Immune Drug Discovery"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00125-003-1320-4","article-title":"Effects of insulin-sensitising agents in mice with hepatic insulin resistance","volume":"47","author":"Cohen","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1358\/dof.2008.033.07.1229229","article-title":"Saxagliptin","volume":"33","author":"Cole","year":"2008","journal-title":"Drugs Fut."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0260","doi-asserted-by":"crossref","unstructured":"DeFronzo, R.A., Goodman, A.M., and the Multicentre Metformin Study Group, 1995. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. New Engl. J. Med. 333, 541\u2013549.","DOI":"10.1056\/NEJM199508313330902"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0050","first-page":"101","article-title":"Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding","volume":"13","author":"Gao","year":"2005","journal-title":"Chinese Journal Chin. J. Hepatol."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0055","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1210\/jc.2002-021225","article-title":"Efficacy of glyburide\/metformin tablets compared with initial monotherapy in type 2 diabetes","volume":"88","author":"Garber","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/diabetes.52.1.21","article-title":"Reduction of protein tyrosine phosphatase 1b increases insulin-dependent signaling in ob\/ob mice","volume":"52","author":"Gum","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0065","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1523-1755.2004.00859.x","article-title":"Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes","volume":"66","author":"Guorong","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0070","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1210\/en.2004-0219","article-title":"Genetic background (C57BL\/6J versus FVB\/N) strongly influences the severity of diabetes and insulin resistance in ob\/ob mice","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0075","series-title":"Wiener Klinische Wochenschrift: Supplementum","first-page":"180","article-title":"European Fructosamine Workshop","author":"Henrichs","year":"1990"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0080","unstructured":"Hodge, K.L., Sharma, S., Borstel, R.W.V., Wolpe, S.D., 2010. US Patent No. 7, 645, 772 B2. Date of patent, Jan 12."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0085","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1745-7254.2006.00427.x","article-title":"Antidiabetic effect of a novel non-thiazolidinedione PPAR\u03b3\/\u03b1 agonist on ob\/ob mice","volume":"27","author":"Hu","year":"2006","journal-title":"Acta Pharmacol. Sini."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4142\/jvs.2009.10.3.189","article-title":"Anti-obesity activity of diglyceride containing conjugated linoleic acid in C57BL\/6J ob\/ob mice","volume":"10","author":"Hue","year":"2009","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0095","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0100","doi-asserted-by":"crossref","first-page":"E1125","DOI":"10.1152\/ajpendo.00430.2002","article-title":"Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats","volume":"284","author":"Ida","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1463-1326.2004.00407.x","article-title":"The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects","volume":"7","author":"James","year":"2005","journal-title":"Diab. Obesity Metab."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(83)90078-5","article-title":"Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control","volume":"127","author":"Johnson","year":"1983","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0115","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrd895","article-title":"Protein tyrosine phosphatase 1B inhibitors for diabetes","volume":"1","author":"Johnson","year":"2002","journal-title":"Nature Rev. Drug Dis."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0120","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1074\/jbc.271.33.19810","article-title":"Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I stimulated signaling","volume":"271","author":"Kenner","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0125","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/diabetes.55.03.06.db05-0917","article-title":"Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance","volume":"55","author":"Kim","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0130","doi-asserted-by":"crossref","first-page":"8748","DOI":"10.1074\/jbc.M505649200","article-title":"Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and independent pathways","volume":"281","author":"Kubota","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0135","doi-asserted-by":"crossref","unstructured":"Kurundkar, S.B., Sachan, N., Kodam, K., Kulkarni, V.M., Bodhankar, S.L., Vanage, G., D'Souza, S., Ghole, V.S., in press. A novel biphenyl compound, VMNS2e, ameliorates streptozotocin induced diabetic nephropathy in rats. J. Diabetes. doi:10.1111\/j.1753-0407.2010.00094.x.","DOI":"10.1111\/j.1753-0407.2010.00094.x"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0140","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses nonalcoholic fatty liver disease in obese leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nature Med."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0145","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1100\/tsw.2007.117","article-title":"The physiology of obese-hyperglycemic mice (ob\/ob mice)","volume":"7","author":"Lindstr\u00f6m","year":"2007","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0150","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/jm990476x","article-title":"New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties","volume":"43","author":"Malamas","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jn\/132.2.176","article-title":"Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test","volume":"132","author":"Martins","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/jpet.106.104950","article-title":"Glucocerebroside ameliorates the metabolic syndrome in ob\/ob mice","volume":"319","author":"Margalit","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2005.06.172","article-title":"Diabetic changes in the redox status of the microsomal protein folding machinery","volume":"334","author":"Nardai","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/diabetes.49.5.735","article-title":"Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose a direct metformin effect on pancreatic \u03b2-cells","volume":"49","author":"Patan\u00e8","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0175","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.2174\/1381612043382954","article-title":"Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity","volume":"10","author":"Pei","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/07853899009147912","article-title":"Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial","volume":"22","author":"Pentik\u00e4inen","year":"1990","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0185","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jnutbio.2007.08.009","article-title":"Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice","volume":"19","author":"Plummer","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/014107688908200213","article-title":"The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy","volume":"82","author":"Rains","year":"1989","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1677\/joe.0.1550055","article-title":"Improvement of glucose homeostasis and hepatic insulin resistance in ob\/ob mice given oral molybdate","volume":"155","author":"Reul","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0200","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/diabetes.51.7.2037","article-title":"Isomer-dependent metabolic effects of conjugated linoleic acid","volume":"51","author":"Roche","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14756360601051274","article-title":"Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation","volume":"22","author":"Sachan","year":"2007","journal-title":"J. Enz. Inh. Med. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0210","first-page":"1625","article-title":"Substituted biphenyl ethanones as antidiabetic agents: synthesis and in-vivo screening","volume":"1","author":"Sachan","year":"2009","journal-title":"Int. J. Pharmatech. Res."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0215","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","article-title":"Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes","volume":"29","author":"Schwartz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0220","first-page":"E742","article-title":"Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone","volume":"271","author":"Sreenan","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0225","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/japplphysiol.00255.2006","article-title":"Metformin increases the PGC-1\u03b1 protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo","volume":"101","author":"Suwa","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0230","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.275.13.9792","article-title":"Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. a brute force approach based on \u201csubstrate-trapping\u201d mutants","volume":"275","author":"Walchli","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0235","first-page":"104","article-title":"Metformin induced anorexia and weight loss","volume":"62","author":"Wong","year":"2003","journal-title":"Hawaii Med. J."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0240","doi-asserted-by":"crossref","first-page":"549P","DOI":"10.1046\/j.1365-2125.2002.161311.x","article-title":"The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus; a systematic review","volume":"53","author":"Wulffele","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.09.067_bb0245","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hep.510310313","article-title":"Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage","volume":"31","author":"Xabier","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/13543784.12.2.223","article-title":"PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity","volume":"12","author":"Zhang","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2010.09.067_bb0255","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.142298199","article-title":"PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice","volume":"99","author":"Zinker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991000988X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991000988X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T22:04:32Z","timestamp":1591999472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991000988X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S001429991000988X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.067","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}